Skip to content
healthcare.dev

FASENRA

NDC 0310-1730, Benralizumab, injection, solution, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-1730
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761070
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-1730 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENRALIZUMAB30 mg/mL

Pharmacologic classes

Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]; Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
0310-1730-30003101730301 SYRINGE, GLASS in 1 CARTON (0310-1730-30) / 1 mL in 1 SYRINGE, GLASS
0310-1730-85003101730851 SYRINGE, GLASS in 1 CARTON (0310-1730-85) / 1 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da6aca1a-19ed-44a4-abb7-696c7d58b784
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0310-1730

Use it

Look up 0310-1730 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-1730 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-1730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.